Cochlear implant (CI) is a successful device to restore hearing. Despite continuous development, frequency discrimination is poor in CI users due to an anatomical gap between the auditory neurons and CI electrode causing current spread and unspecific neural stimulation. One strategy to close this anatomical gap is guiding the growth of neuron dendrites closer to CI electrodes through targeted slow release of neurotrophins. Biodegradable calcium phosphate hollow nanospheres (CPHSs) were produced and their capacity for uptake and release of neurotrophins investigated using 125 I-conjugated glia cell line-derived neurotrophic factor (GDNF). The CPHSs were coated onto CI electrodes and loaded with neurotrophins. Axon guidance effect of slow-released neurotrophins from the CPHSs was studied in an in vitro 3D culture model. CPHS coating bound and released GDNF with an association rate constant 6.3 Â 10 3 M À1 s À1 and dissociation rate 2.6 Â 10 À5 s À1 , respectively. Neurites from human vestibulocochlear ganglion explants found and established physical contact with the GDNF-loaded CPHS coating on the CI electrodes placed 0.7 mm away. Our results suggest that neurotrophin delivery through CPHS coating is a plausible way to close the anatomical gap between auditory neurons and electrodes. By overcoming this gap, selective neural activation and the fine hearing for CI users become possible.
Introduction
Cochlear implants (CIs) have been used to restore hearing in patients with profound hearing loss for several decades. The results are generally good, especially in children. A CI bypasses a dysfunctional sensory epithelium and directly stimulates the spiral ganglion neurons with short biphasic electric pulses. The first multi-electrode CIs were developed to treat patients with profound sensorineural hearing loss in the 1970's [1] . Thereafter, there have been continuous updates with different coding strategies to improve the conversion of sound into digital signals that can be interpreted by the auditory nerve [2] . The electronics (processor and receiver) have also been improved whilst the design of the electrode arrays have undergone rather few modifications. The functional outcome with CIs varies between patients and seems to have reached a plateau; no improvement, as to mean recognition of monosyllabic words in post-lingual deafened adults, has been achieved for decades [3, 4] .
One problem is the inability of CIs to deliver independent signals to individual spiral ganglion neurons [5, 6] . Efforts were made to organize the growth of neurites on implant surfaces and increase the total electrode count [7, 8] , as CIs typically employ 12e22 electrodes to replace the function of 3400 auditory inner hair cells. Although promising, this strategy requires the auditory neurons to have direct contact with the implant electrode. A first obstacle is the anatomical gap between the CI electrode and the auditory neurons; the electrode is inserted into the perilymph-filled scala tympani, through which neurons cannot grow. Edin et al. (2014) demonstrated that re-sprouted human vestibulocochlear neurons can grow through gels, which opened up possibilities for regenerating auditory neurons to traverse the perilymph barrier and reach the CI electrode [9] . Perilymph would thus be replaced with a nerve-stimulating gel to bridge the gap between the auditory neurons and the CI electrode. An even harder task remains to guide the growth of auditory neurons through the gel and form direct physical contact with the CI electrode. If such an interface was accomplished, it could result in lower stimulation thresholds, which in turn allows for selective neural stimulation and improved sound quality and speech perception. A lower stimulation threshold would also necessitate less power in each pulse and would reduce CI battery consumption e another bottleneck of the device [5,10e12] .
As the CI depends on functional spiral ganglion neurons, extensive research on their survival, regeneration, and guidance has been conducted, including attracting and repelling guidance cues. Netrin-1 attracted growth cones from regenerating guinea pig spiral ganglion neurons in vitro [13] . Brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) increased the innervation of separated murine organ of Corti explants when co-cultured with spiral ganglion neurons [14] . Several in vivo studies have confirmed these results by successfully regenerating peripheral extensions in animals with ablated hair cells [15e18]. Regeneration based on long-term chronic infusion of nerve growth factors [16] may not be desirable in clinic because of the risk of infections. Additional strategies involve adenoviral gene therapy to overexpress glia cell line-derived neurotrophic factor (GDNF) and protect hair cells [19] . Close-field electroporation of gene fragments for producing BDNF using a CI resulted in regeneration of spiral ganglion neurites in a guinea pig model. Neurites extended closer to the CI electrode and yielded lower stimulus thresholds in a CI array [17] . Another strategy to provide long-term administration is to coat a CI with cells genetically modified to overexpress neurotrophic compounds [20] . However, these approaches do not necessarily provide the desired gradient stimulating physical contact between spiral ganglion neurons and CI, since neurotrophins are randomly expressed. Safety issues also remain to be solved before considering clinical applications. Therefore, a combination of targeted neurotrophin release and neural growth stimulating gel could be a more reasonable strategy, as the delivery of neurotrophins using mesoporous silica supraparticles has already been shown to prevent the death of spiral ganglion neurons in the guinea pig model [18] .
Here, we developed a delivery approach to coat CI electrodes with calcium phosphate hollow nanospheres (CPHSs) loaded with neurotrophins. Calcium phosphates have been used as drug carriers and hollow spheres can host drugs with high loading and sustained release. Calcium phosphates were proven to be suitable for the delivery of high-molecular-weight growth factors [21, 22] . From safety aspects, calcium phosphates are the main components in human bones and teeth, making them ideal candidates for clinical use. Previous studies show CPHSs are synthesized via a mineralization process under high temperatures [23] . It has been used in ranges of bone grafts in healing models with no signs of toxicity [24, 25] . To date, calcium phosphate is clinically used, e.g. as bone fillers. It is not known whether calcium phosphate has been used in the cochlea, but hydroxyapatite is frequently used to repair the vestibular part of the temporal bone treating patients with superior semicircular canal dehiscence without showing adverse effects [26] . Calcium phosphate is also used in dietary supplements and in approved drugs such as Calfovit D3. It can be degraded in vivo and is considered to be safe when calcium and phosphate ions are released in the human body.
By coating CI electrodes with neurotrophin-loaded CPHSs, we believe a sustained release of the neurotrophins can be established when operated into patients. These guidance cues would be able to attract the growth of regenerating auditory neuron dendrites through bioactive gels and finally establish direct physical contact between the auditory neurons and the CI electrodes ( Fig. 1 ). To verify our hypothesis, an in vitro sustained release 3D model was Fig. 1 . An illustration of spiral ganglion neurons guided toward a CI electrode. By attracting neurons using neurotrophic stimulation and replacing the perilymph with an extracellular gel matrix, the anatomical gap between the auditory nerve and electrode could be closed. Peripheral dendrites grow from modiolus (*) via osseous spiral lamina (**) and through habenula perforata (***) to scala tympani. Another route is growing directly through canaliculi perforantes (arrow). Reduced distance will result in minimized current spread from the CI, enabling the use of a higher number of non-overlapping stimulation points (adapted from Rask-Andersen et al., 2012). established and tested.
Material and methods

Synthesis and characterization of calcium phosphate hollow nanospheres
All chemicals were purchased from Sigma without purification before use. CPHSs were synthesized using the following procedure: NaCl (136.9mM9, KCl (2.7 mM), Na 2 HPO 4 (8.1 mM), KH 2 PO 4 (1.5 mM), CaCl 2 (0.9 mM), MgCl 2 ˑ6H 2 O (0.5 mM) were dissolved one by one in the deionized water to form a clear phosphate buffer solution. The final pH value is 7.4. The obtained solution was then put into a tightly sealed glass bottle at 100 C for 24 h. The precipitation was separated by centrifuging and washed with ethanol and water.
The morphology and size of spheres were analyzed by field emission scanning electron microscopy (FESEM, LEO 1550). Their hollow structure was analyzed by transmission electron microscopy (TEM, Hitachi 7100). Briefly, the spheres were embedded in Lowicryl (EMS, Hatfield, PA, USA) and ultrathin sections acquired before analyzing. The crystal phase of the specimens was analyzed using x-ray diffractometry (Siemens Diffractometer 5000) using Cu Ka radiation (l ¼ 1.5418 Å). The N 2 adsorption and desorption (Micromeritics 2020) was used to analyze the surface area and pore size of the particles.
Slow release characteristics
The in vitro slow release properties of the nanoparticles were studied using the LigandTracer Grey Instrument (Ridgeview Instruments AB, Uppsala) detecting low energy gamma radiation. This approach has previously been used to monitor the slow release properties of nanoparticles [27e29]. Measurements were made in Hepes-buffered (10 mM) artificial perilymph (AP) containing 137 mM NaCl, 5 mM of KCl, 2 mM of CaCl 2 and 1 mM MgCl 2 (all from Sigma-Aldrich, Stockholm, Sweden).
The GDNF used in the in vitro cultures was 125 I-conjugated using a chloramine-T reaction as previously described [30] . Two 5 mL drops of a 2% CPHS suspension were deposited in separate spots on a Petri dish and 30 mL of 8 mg/mL Matrigel (Corning, NY, USA) was added to anchor them to the surface. After careful mixing, the gels covered roughly 1 cm 2 . As a reference, gel containing 5 mL of PBS and 30 mL of Matrigel was placed in another position of the same dish and treated the same way. The dish was then transferred to 37 C for 30 min. Uptake was measured at room temperature by adding 200 ng 125 I-labeled GDNF in a total volume of 3.2 mL (5.4 nM) at room temperature and monitoring the binding for 23 h (Fig. 2) . To obtain the specific uptake by CPHS, the signal obtained from the pure gel position was subtracted from the signal obtained from the CPHScontaining gel.
The GDNF solution was then removed and 5 mL AP was added; dissociation was then measured for at least 7 h at room temperature. After that, dissociation at 37 C was measured for at least 17 h by replacing the buffer with 5 mL of fresh AP equilibrated at 37 C and placing the dish in a temperature-equilibrated instrument placed inside a heating cabinet at 37 C. All of the signals were corrected for the radioactive decay of 125 I over time. Uptake and retention was measured in triplicate. Measurements were also performed on Matrigel containing only cellulose to investigate its uptake potential. To estimate the relationship between counts per second and the amount of bound GDNF, a 20 mL drop of the 1 mg/mL 125 I labeled GDNF solution was applied to a dry, CPHS-free gel prepared as above. The 125 I signal was then measured for a few hours.
Inner ear ganglion samples
The use of human material was approved by the Regional Ethical Review Board (Uppsala, no. 99398, 22/9 1999, cont., 2003, Dnr. 2013/190) and conducted in conformity with the Declaration of Helsinki principles. After informed consent, part of the Scarpa's ganglion or spiral ganglion was acquired from surgical waste from patients undergoing translabyrinthine surgery to remove lifethreatening acoustic neuromas (n ¼ 4 adults). Temporal bones from euthanized neonatal mice (C57BL/6, P8) were donated to us by a neighboring group according to ethical approval (Dnr. C346/11 and C1/15). The modiolus was isolated using stereo microscope.
3D explant culture
Biopsies were transferred in Leibovitz's L-15 medium on ice and washed three times in PBS to remove excessive blood. The culture protocol was adapted from Edin et al. (2014) [9] . Briefly, the growth-factor-reduced Matrigel (Fisher Scientific, Waltham, MA) was diluted to a final concentration of 4 mg/mL in culture medium containing Neurobasal medium supplemented with B27 (1x), 2 mM L-glutamine, and 0.04% gentamicin (all from Life Technologies, Stockholm). Biopsies were embedded in 50 mL of the gel together with CI electrodes coated with empty nanoparticles or nanoparticles pre-loaded with BDNF or GDNF (both from R&D systems, Minneapolis, MN). The gel was allowed to set for 30 min at 37 C in a humidified incubator with 5% CO 2 before being covered with culture medium (z2 mL). Cultures were maintained in a humidified incubator at 37 C, 5% CO 2 and medium was replaced every 3 days.
Coating of cochlear implant electrodes
Fragments of CI electrodes were coated with 0.075%e2.5% CPHS diluted in a 1% cellulose (MW 9000, Sigma Aldrich) suspension. To selectively coat the platinum/iridium electrodes, the CPHS/cellulose suspension was vortexed vigorously before applying 0.2 mL to the electrode contacts using a 1 mL Hamilton syringe under a stereo microscope. The coating was dried in a dry heat oven overnight at Nanoparticles were encapsulated in Matrigel near the rim of a 10 cm petri dish, which was allowed to set. Measurements were made in 3.2 mL of artificial perilymph (AP) containing 200 ng 125 I-conjugated GDNF for 23 h. The dish was rotated at 1 RPM through the solution with the labeled ligand, and each measuring point was continuously monitored. The release properties were measured by replacing the 125 I-containing suspension with 5 mL of fresh AP, and the decrease in signal was recorded as the 125 I-GDNF was released. 37 C. Subsequently 20 ng/0.2 mL of GDNF or BDNF were added to the coating and allowed to absorb overnight at 37 C under dry heat. The general coating was performed by immersing the whole CI electrode into a small drop of the CPHS/cellulose suspension. Growth factors were loaded in the same way as for the selective coating.
Immunofluorescence
Explants were stained as whole mounts in the gel. In short, the samples were washed in PBS, fixed in 4% formaldehyde for 30 min, washed again and blocked using 2% BSA/PBS at 37 C for 2 h. Rabbit anti-neuronal class III b-tubulin (Tuj1) clone EP1569Y (Merck Millipore, Billerica, MA) was diluted 1/1000 in 2% BSA/PBS and incubated with the gel for 4 days at 4 C, followed by washing. The Alexa conjugated secondary antibody was diluted 1/500 and applied to the gel overnight at 4 C before wash and being examined using fluorescence microscopy and laser scanning confocal microscopy.
Ultrastructural characterization
Co-cultured electrodes were fixed in 2.5% glutaraldehyde for 1 h, followed by a dehydration step through a series of ethanol dilutions from 70%e99.5% for 1 h each. The specimen was stored in 99.5% ethanol for up to 3 months before gold sputtering; the morphology was determined by FESEM (LEO 1550).
Results
Characterization of CPHS and coatings
The CPHS were found to be spherical with an average size of 600 nm based on SEM analysis. TEM analysis shows these spheres were hollow ( Fig. 3a) . XRD results confirm that the phase is tricalcium phosphate (Fig. 3b ). The BET analysis shows the surface area of spheres is 18.9 cm 2 /g, and average pore size is 16.3 nm. SEM observations revealed that CPHSs were able to form a layer on the platinum/iridium electrode contact at a concentration of 0.75 mg/ mL (Fig. 3cef) . A thin film of cellulose was covered on the CPHSs to stabilize them on the electrode. Even at much lower concentrations of 0.075 mg/mL (S. 1), the coating was able to be established on the electrode.
Uptake and slow release characteristics
The signal quantification experiment resulted in a signal of 357 counts per second for 20 ng GDNF, which means 1 count per second corresponds to the uptake of 56 pg of GDNF. Each gel drop contains approximately 95 ng of nanoparticles. Measurements show that the GDNF-uptake in each spot is around 10 ng, with a theoretical maximum of 20 ng. This means that the measured uptake is 0.1 ng of GDNF per 1 ng of nanoparticle. The theoretical maximum uptake is around 0.21 ng of GDNF per 1 ng of nanoparticle. GDNF uptake in the pure Matrigel and 1% cellulose was close to background and reached an equilibrium level of roughly 0.8 ng GDNF within 1 h (S. 2).
GDNF uptake by gels containing CPHSs showed the same initial uptake of GDNF as the pure gel, but the signals increased continuously and did not reach equilibrium within the time that uptake was monitored, i.e., 17e23 h. Subtracting the signals from the pure gel from the nanoparticle-containing gels yields the specific uptake by the nanoparticles. After 23 h, the average uptake levels per spot for the triplicate experiment amounted to 10.4 ± 2.1 ng GDNF (Table 1) .
At room temperature, the GDNF release follows a single exponential decay, and roughly 50% of GDNF was released in 7 h. When transferred to 37 C, dissociation was clearly biphasic. One third was released within 3 h, after which the release rate slowed down considerably (Fig. 4) . After 17 h, roughly 50% of the GDNF was left from the starting point of the 37 C release measurement. The uptake and release patterns at room temperature were fitted to a Langmuir binding model thus assuming that the nanoparticles contain a discrete number of binding sites for GDNF with identical affinity. This resulted in an association rate constant of 6.3 Â 10 3 M À1 s À1 , a dissociation rate of 2.6 Â 10 À5 s À1 , and an affinity of 4.5 nM. The average GDNF binding level at saturation was estimated to be 20.1 ± 6.7 ng per spot. 
. Random injections
The GDNF-loaded CPHSs were randomly injected into the gel close to a spiral ganglion explant. The CPHS aggregated into larger clusters and formed visible shapes. After allowing co-culture for 7 days, axons sprouted from the explant and grew toward areas where the CPHS concentration seemed to be higher and followed randomly formed lines by CPHSs. Axons in the human vestibular nerve stained positive for the neuronal marker Tuj1, confirming the specificity of the antibody (S. 3).
General coating
The fully-CPHS-coated electrodes could be easily distinguished from the uncoated ones under a stereo microscope. The coated electrodes looked dull, and whiter areas indicated regions of thicker CPHS coating (S. 4a); a large amount of gathered coating mixture was around the metal wire endings of electrode fragments (S. 4b). When loaded with GDNF, human Scarpa's ganglion neurites appeared to be more attracted to these larger coating deposits (S. 4c). A time-lapse video recording of 24 h showed the neurites from the explant growing toward the thicker coating on the metal wire endings of the CI electrode. At first, a few cells were attracted to the coating, and then additional cells migrated toward the metal wires forming thick cell bundles (S. 5). Volume-rendered confocal Z-stacks images showed the cells growing onto the GDNF-coated electrode were Tuj1 positive (S. 6).
Supplementary video related to this article can be found at http://dx.doi.org/10.1016/j.biomaterials.2016.12.020.
The influence of the growth factors on the sprouting neurites were studied through the loading of various growth factors onto the CPHS coating and then by placing the coated electrodes equidistant from an inner ear ganglion explant (Fig. 5 ). After 11 days in co-culture, cells from human Scarpa's ganglion explant grew randomly in the gel surrounding the control-coated electrode (Fig. 5c, f) but were attracted to the GDNF-and BDNF-coated electrodes (Fig. 5d , e, g and h). Rotating 3D volume rendered Zstack images displayed that most of the cells were growing on the GDNF-coated electrode, and only a few cells grew randomly in the gel nearby the electrode (S. 7).
Selective coating
The coating was performed selectively on the CI electrode contacts and examined before being placed in culture, ensuring the silicone protection sheath of the electrode remained uncoated. The coating made the blank platinum/iridium surface look dull (Fig. 6a ). Neurites sprouted from the human Scarpa's ganglion ( Fig. 6b and c) and spiral ganglion explants (S. 8) and grew toward and onto the GDNF-coated electrode. The sprouted neurites stained positive for the neuronal marker Tuj1 (Fig. 6c ). After removing the surrounding gel, the electrode was scanned and a 3D-reconstruction of Zstacked images was made to confirm that the neural extensions were anchored on the coated electrode ( Fig. 6d ). Neurites from murine spiral ganglion explants were also attracted by the GDNFand BDNF-coated CI electrodes. The cells selectively grew toward the coated surface and ignored the silicone protection sheath (Fig. 6e ). 3D-reconstruction of the Z-stacked images demonstrated that Tuj1 positive neural extensions not only grew on the coating but also encircled the electrodes (Fig. 6f and g) . SEM observations revealed neural extensions anchoring the coated electrode surface, and the CPHS coating seemed stable after 14 days of co-culture in gel and 3 months in ethanol (Fig. 7) . . 4 . GDNF uptake and release curves from LigandTracer experiments. (a) A representative curve of the uptake and release of GDNF at room temperature. (b) The continued release was monitored after the dish was moved to 37 C. The data was normalized, and the curves show the release properties of both the measuring points at 37 C during 16 h for the three duplicate experiments (n ¼ 6).
Discussion
In this study we demonstrated for the first time that neurons harvested from the human vestibulocochlear nerve can grow and form direct physical contact with CI electrode surface after expansion in a 3D gel matrix. This was achieved by coating the electrodes with neurotrophin-loaded CPHSs. The sustained release of neurotrophins from CPHS coatings attracted the neurites toward and eventually formed physical contact with a CPHS-coated CI. This finding is of particular interest as it may be a key toward a gapless neural-electrode interface.
The current CI activates neurons located some distance from the electrode. It requires larger stimulation currents and at the same time limits the amount of possible non-overlapping stimulation points. The activated auditory neuron will receive stimulations from a broad spectrum of frequencies, which results in poorer frequency discrimination. Physical contact could potentially enable the use of smaller currents to reach the stimulation thresholds of the attached auditory neurons and minimize current spread. This would further enable selective activation of neurons through a larger number of stimulation points. Considering the normal 3400 human inner hair cells providing principal afferent information to the brain, an obvious prerequisite for improved electric hearing is providing more stimulation points to give a higher resolution of sounds. A possible way to do this could be the introduction of micro-sized electrodes as recently described [7, 31] .
Previous studies show that the delivery of neurotrophins into the cochlea e e.g., through catheters or transfection through Fig. 5 . Generally coated CI electrode fragments were placed equidistant from the human Scarpa's ganglion explant at day 0 (a) in a gel drop and were allowed to co-culture for 11 days (b). The coatings were loaded with several growth factors including N ¼ netrin-1, CPS ¼ control, G ¼ GDNF, B¼BDNF, C ¼ uncoated control. A 3D reconstruction of Z-stacked images visualized the distribution of cells in the gel surrounding the coated electrodes (c, f). The control-coated surface did not attract the growth of cells onto the electrode; the cells grew randomly in the gel. Both BDNF-(d, g) and GDNF-coated (e, h) CI electrode fragments attracted the growth of cells onto the coated surfaces. The co-cultures were observed vertically (c, d and e) and horizontally (f, g and h) in the gel. Green is DAPI; electrode contacts and metal wires reflect light and were therefore also visualized. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) electroporation, may increase the survival of spiral ganglion neurons and guided periphery dendrites closer to the scala tympani [16, 17] . Clinically, the use of catheters poses infection risks. Gene therapies are still controversial and may be unsuitable for guiding neurites to a CI as the neurites will likely be attracted to the neurotrophin-expressing cells rather than the CI electrode. Growth factor delivery using biodegradable particles as carriers provides another option for axonal guidance. Recent approaches using mesoporous silica supraparticles placed in the scala tympani as a drug carrier showed that they could deliver sufficient amounts of BDNF into the cochlea to have a neuroprotective effect [18] , demonstrating the usefulness of porous particles as drug carriers in vivo. We chose in this study to use CPHS not only because of its hollow and porous nature, which allows it to load growth factors and release those slowly into the surrounding environment [23] , but also that CPHS is more stable if comparing the degradation with hydrogel. Additionally, calcium phosphate is a major constituent of bone and thus provides an endogenous environment for the neurons to grow on.
Histological studies have shown that the loss of auditory hair cells frequently results in a retraction or loss of the peripheral dendrite along the osseous spiral lamina. Unlike animals, the human auditory neuron soma located in the modiolus is mostly preserved and remains excitable [32] . Thus, monopolar neurons are potentially capable of re-sprouting and forming a new peripheral dendrite. Theoretically, such a growth seems possible and could extend through the canals in the habenula perforata. From there, we believe it is possible for the dendrites to reach the scala tympani and the CI electrode through a gel. The distance between the habenula perforata and the CI electrode is less than 0.5 mm depending on electrode placement. The total travel length between the modiolus and CI electrode varies from 1 to 1.5 mm between the basal and apical turn of the cochlea (Fig. 1) . Another possibility is that axons can grow through the caniculi perforantes in the modiolar wall; in that case, the travel distance is significantly shorter [16] . In the present study, we were able to attract regenerated sprouting neurites from primary cultured vestibulocochlear ganglion at a distance of roughly 0.7 mm in a 3D matrix through GDNF slow release via CPHSs. This distance may be sufficient with a CI placement near the modiolar wall; however, in patients who have suffered hearing loss for a longer period, the peripheral dendrites may have retracted back to the modiolus [33, 34] . In this case, it would be much harder to attract them to CI electrodes.
There are two GDNF dimers in one asymmetric unit of crystal with cell dimension (a ¼ 6.785 nm, b ¼ 6.755, c ¼ 7.140) (PDB code: 1AGQ). The size of GDNF is smaller than the pore size of the shell. Based on the loading method we used, GDNF could be adsorbed on the surface and soaked into the spheres. The uptake and release characteristics of the CPHS were demonstrated using the Ligand-Tracer technique. The retention curves initially showed the release of about 50% after 6 h with slower release kinetics after that timepoint. The curves leveled off and stabilized within 17 h. The release from 6 to 17 h showed an almost linear way, and the release rate was 1.6% per hour. This should be a release by diffusion from the spheres because we did not observe a clear degradation of the spheres. If this release process continues, it takes about 100 h before 90% of the GDNF is released. The release would be controlled by both diffusion and degradation of the spheres in the later stage. The last part of GDNF will be released more slowly. The release of GDNF could be separated into three stages: (1) the fast initial release is most likely due to GDNF adsorbed to the surface of the nanoparticles, (2) the retention rate decreases as GDNF is trapped with high affinity in the interior of the nanoparticles leading to lower release, and (3) the remaining GDNF would be released during the degradation of the coating. The burst release could initiate a higher local concentration which could facilitate the initial neurite extension. A subsequent lower concentration may be sufficient to continue and maintain guidance. The variation between the runs may be explained by the nature of the particles, as they form aggregates that cannot be completely re-suspended, causing variations in the sheer number of particles in each experiment. The variations in numbers and level of aggregation will also affect the particles' uptake and release since surrounding particles in the media can act as a steric hindrance. The release experiments were performed in a 5 mL volume, similar to the in vitro model rather than the human cochlea, which has a total volume of 100 mL [35] . In a smaller volume, the release rate would most likely be lower since GDNF concentration is expected to be higher near the surface of the implant where there is a continuous dynamic uptake and release by the nanoparticles. Previous in vivo studies have shown increased spiral ganglion neuron survival and peripheral dendrite regeneration 3 weeks after BDNF and NT3 treatment [15] , in vitro studies suggested spiral ganglion neurons could form new synapsis within 6 days [14] . It is however not known the clinical time required for spiral ganglion neuron regeneration in patients as this depends on the regeneration capacity which may involve individual factors such as patient age and duration of deafness.
Despite the advantages of a CPHS coating, including the wide use of calcium phosphate in clinics and drugs, as well as its safety records, there are still important issues to consider before we move on to in vivo studies. First thought is regarding the stability. Our in vitro studies suggested the coating was stable enough to survive CI insertion into human cochlea through round window, we believe it is possible because the coating was protected by the unbendable concavity on the silicone CI electrode protection sheath (S. 9). The aggregation of CPHS particles in the coatings was observed. For the whole CI surface, the coating, in general, was homogeneous, but, in small areas, the distribution of CPHS was inhomogeneous. The aggregation of CPHS in the cellulose solution cannot be avoidable in this experiment. The particles are easy to aggregate together in cellulose based matrix. The concentration of CPHS would also influence the homogeneity. The low concentration of CPHS is easy to get the well distribution of the particles in the coating (S. 1). In fact, the aggregation of CPHS (at the present concentration) in the coating did not affect the release of GDNF, and further guide neuron growth. Secondly, although biodegradable, it is not known whether CPHS breakdown is harmful to the ear and the residual neurons if the concentrations of calcium phosphate ions are at an elevated level. CPHS itself is a bioactive material and can induce the accumulation of calcium and phosphate ions on its surface. If the degradation gradually happens over the long-term, a redeposit of calcium and phosphate ions could be initiated in the coating. Part of the released ions could not potentially lead to ossification, which could influence CI function and outcome. Furthermore, redeposits of calcium phosphate could attract growth factors released in the gel and prolong the release. An important issue is whether neurites can survive after the GDNF supply has been depleted. Typically, the neural outgrowth is accompanied by the migration and alignment of glial-or Schwann cells that envelope the neurite [9] . Such alignment could also be observed in this study (S. 5). Without protecting alignment, the neurite will not survive long-term. These glial cells may continue producing stimulating growth factors including GDNF in situ to support the neurite. Another contributing factor is the electrical stimulation that the neurons will receive from CI. In vivo studies have demonstrated that electrical stimulation from CI promotes survival of spiral ganglion neurons [36, 37] . This may be of higher importance in rodents where survival of spiral ganglion neurons is dependent on hair cells. In humans, however, the situation is different as spiral ganglion neurons can survive without hair cells. This partly explains why CI still works in patients with long deafness duration. In vivo studies are necessary to settle these effects and should be considered.
Conclusions
In summary, we have demonstrated the use of CPHS as a coating to increase the biocompatibility of CI electrodes. The CPHSmediated slow release of growth factors attracted regenerated vestibulocochlear neural extensions growing towards and on the coated electrode surfaces and significantly reduced the distance between the CI electrodes and neural elements. This technique could potentially improve the outcome of CIs, however animal studies are necessary to evaluate its effects in vivo.
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